Background
Methods
Patients
Definitions
OCT - acquisition and analysis
Statistical analysis
Results
BVS (n = 26)
|
EES (n = 34)
|
P-value
| |
---|---|---|---|
Age, years | 54.0 ± 11.2 | 61.7 ± 11.4 | 0.012 |
Male, n (%) | 19 (73) | 30 (88) | 0.122 |
Diabetes
| |||
No, n (%) | 18 (69) | 25 (74) | |
NIDDM, n (%) | 5 (19) | 9 (26) | 0.117 |
IDDM, n (%) | 3 (12) | 0 | |
Hypertension, n (%) | 15 (58) | 25 (74) | 0.156 |
Hyperlipidemia, n (%) | 17 (65) | 21 (62) | 0.494 |
Positive family history, n (%) | 6 (23) | 10 (29) | 0.402 |
Smoking
| |||
No, n (%) | 15 (58) | 9 (26) | |
Ex, n (%) | 2 (8) | 13 (38) | 0.011 |
Current, n (%) | 9 (34) | 12 (36) | |
Indication for PCI
| |||
ACS - STEMI, n (%) | 3 (12) | 1 (3) | |
ACS - NSTEMI, n (%) | 7 (27) | 6 (18) | 0.237 |
Non-ACS elective, n (%) | 16 (61) | 27 (79) | |
LAD, n (%) | 19 (73) | 19 (56) | |
CX, n (%) | 3 (11) | 9 (26) | 0.261 |
RCA, n (%) | 4 (15) | 5 (15) | |
Ramus intermedius, n (%) | 1 (5) | 0 | |
Lesion classification
| |||
Type B1, n (%) | 16 (62) | 24 (70) | |
Type B2, n (%) | 5 (19) | 5 (15) | 0.407 |
Type C, n (%) | 5 (19) | 5 (15) |
BVS (n = 40)
|
EES (n = 40)
|
P-value
| |
---|---|---|---|
Nominal diameter, mm | 3.23 ± 0.34 | 3.07 ± 0.54 | 0.124 |
Length, mm | 21.80 ± 5.62 | 21.13 ± 9.21 | 0.693 |
Stenosis, % | 81 ± 14 | 89 ± 14 | 0.023 |
Inflation time, sec | 44 ± 13 | 26 ± 8 | <0.001 |
Inflation pressure, atm | 13 ± 3 | 13 ± 3 | 0.799 |
Predilatation, n (%) | 34 (85) | 23 (58) | 0.006 |
Predilatation-ballon diameter, mm | 2.64 ± 0.51 | 2.34 ± 0.46 | 0.026 |
Predilatation-ballon inflation pressure, atm | 13 ± 2 | 12 ± 3 | 0.266 |
Postdilatation, n (%) | 22 (55) | 27 (68) | 0.179 |
Postdilatation-ballon diameter, mm | 3.41 ± 0.47 | 3.27 ± 0.60 | 0.380 |
Postdilatation-ballon inflation pressure, atm | 15 ± 3 | 16 ± 4 | 0.282 |
Postdilatation with NC-ballon, n (%) | 21 (53) | 16 (40) | 0.321 |
Contrast volume, ml | 215.2 ± 150.9 | 213.9 ± 96.8 | 0.963 |
Radiation time, min | 12.1 ± 9.2 | 11.8 ± 6.5 | 0.874 |
OCT results
BVS (n = 40)
|
EES (n = 40)
|
P-value
| |
---|---|---|---|
Plaque type distal stent ending
| |||
Lipid rich, n (%) | 21 (53) | 20 (50) | |
Fibrous, n (%) | 17 (42) | 15 (38) | 0.493 |
Fibro-calcific, n (%) | 2 (5) | 5 (12) | |
Plaque type proximal stent ending
| |||
Lipid rich, n (%) | 23 (58) | 15 (38) | |
Fibrous, n (%) | 8 (20) | 12 (30) | 0.114 |
Fibro-calcific, n (%) | 9 (22) | 13 (32) | |
Plaque type MLA
| |||
Lipid rich, n (%) | 20 (50) | 18 (45) | |
Fibrous, n (%) | 8 (20) | 8 (20) | 0.826 |
Fibro-calcific, n (%) | 8 (20) | 12 (30) | |
Plaque rupture - hematoma, n (%) | 4 (10) | 2 (5) | |
Reference vessel area distal, mm2 | 6.40 ± 2.11 | 6.49 ± 2.57 | 0.879 |
Reference vessel diameter distal, mm | 2.78 ± 0.49 | 2.80 ± 0.64 | 0.854 |
Reference vessel area proximal, mm2 | 8.98 ± 2.55 | 9.43 ± 4.15 | 0.560 |
Reference vessel diameter proximal, mm | 3.37 ± 0.51 | 3.44 ± 0.76 | 0.631 |
Reference vessel area, mm2 | 7.69 ± 2.17 | 7.96 ± 3.30 | 0.668 |
Reference vessel diameter, mm | 3.07 ± 0.44 | 3.09 ± 0.62 | 0.834 |
Distal stent ending area, mm2 | 6.77 ± 2.34 | 6.97 ± 2.75 | 0.721 |
Distal stent ending diameter, mm | 2.88 ± 0.53 | 2.92 ± 0.56 | 0.750 |
Proximal stent ending area, mm2 | 7.48 ± 2.35 | 8.62 ± 3.51 | 0.092 |
Proximal stent ending diameter, mm | 3.04 ± 0.49 | 3.25 ± 0.63 | 0.102 |
Difference nominal diameter-proximal stent ending diameter, mm | 0.19 ± 0.37 | - 0.18 ± 0.52 | <0.001 |
Mean stent area, mm2 | 7.12 ± 2.20 | 7.79 ± 2.30 | 0.257 |
Mean stent diameter, mm | 2.96 ± 0.48 | 3.08 ± 0.57 | 0.984 |
Minimal lumen area, mm2 | 6.38 ± 2.00 | 6.42 ± 2.42 | 0.662 |
Minimal stent diameter, mm | 2.46 ± 0.43 | 2.53 ± 0.54 | 0.537 |
Maximal stent diameter, mm | 3.53 ± 0.52 | 3.31 ± 0.64 | 0.085 |
Stent eccentricity index | 0.69 ± 0.08 | 0.76 ± 0.09 | <0.001 |
Stent symmetry index | 0.30 ± 0.09 | 0.23 ± 0.09 | <0.001 |
RAS, % | 16.99 ± 12.86 | 17.70 ± 11.50 | 0.795 |
Rate of ISA, % | 3.4 ± 1.9 | 2.9 ± 1.9 | 0.720 |
Underexpansion, n (%) | 12 (30) | 14 (35) | 0.812 |
Underexpansion & hematoma, n (%) | 1 (3) | 1 (3) | 1.000 |
Stent fracture, n (%) | 3 (8) | 0 | 0.241 |
Clinical follow-up
BVS (n = 26)
|
EES (n = 34)
|
P-value
| |
---|---|---|---|
MACE, n (%) | 1 (4) | 2 (6) | 1.000 |
Death, n (%) | 0 | 0 | |
MI, n (%) | 0 | 0 | |
TV-Revasc., n (%) | 1 (4) | 2 (6) | 1.000 |
Non-TV-Revasc. n (%) | 0 | 0 |